chr7-102878422-G-T
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000440067.4(FBXL13):c.1687C>A(p.Leu563Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000859 in 1,607,172 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. L563P) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000440067.4 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FBXL13 | NM_001394494.2 | c.1687C>A | p.Leu563Ile | missense_variant | Exon 16 of 21 | NP_001381423.1 | ||
FBXL13 | NM_145032.3 | c.1417C>A | p.Leu473Ile | missense_variant | Exon 15 of 20 | NP_659469.3 | ||
FBXL13 | NM_001287150.2 | c.1417C>A | p.Leu473Ile | missense_variant | Exon 15 of 19 | NP_001274079.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000724 AC: 11AN: 151966Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000171 AC: 42AN: 245734 AF XY: 0.000166 show subpopulations
GnomAD4 exome AF: 0.0000873 AC: 127AN: 1455088Hom.: 0 Cov.: 29 AF XY: 0.0000871 AC XY: 63AN XY: 723606 show subpopulations
GnomAD4 genome AF: 0.0000723 AC: 11AN: 152084Hom.: 0 Cov.: 32 AF XY: 0.000135 AC XY: 10AN XY: 74320 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.1417C>A (p.L473I) alteration is located in exon 15 (coding exon 13) of the FBXL13 gene. This alteration results from a C to A substitution at nucleotide position 1417, causing the leucine (L) at amino acid position 473 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at